HEIDELBERG, Germany, Aug. 14 -- EMBO Molecular Medicine, a peer-reviewed journal that says it features clinical research and basic biology, published research articles on the following topics in its Aug. 12, 2024, edition (Vol. 16, Issue 8):

* LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis

* PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets

* In vitro and in vivo inhi . . .

Click here for more information about our products